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Background
The prospects confronting a ‘‘new-born’’ schistosome cercaria
are formidable. That some of these microscopic helminths
successfully negotiate the tortuous route from snail to human
vasculature is a truly remarkable feature of adaptive biology. After
escaping the birth pore of its parental sporocyst, a cercaria (at least
we infer from studies of other digeneans [1]) swims and crawls
through the snail body cavity before it burrows through a pre-
formed escape tunnel to the aquatic environment. Once in that
milieu, a cyclical suite of swimming behaviours positions the
cercaria for its potential assault on the skin of an available host,
should one appear. Upon skin penetration, the larva (now called a
schistosomulum) sits within the skin for up to 72 hours before
tracking to the lung, whereupon it re-enters a second static phase.
This journey takes the organism through three distinct environ-
ments (five if we include the solid integuments of snail and human
hosts), incorporates a wholesale remodelling of the surface
membrane, and includes two poorly understood periods of relative
immobility in the skin and the lung. Further development in the
liver is required before the adults reach their ultimate destination
in the vasculature of the intestine or bladder. How the juvenile
stages of schistosomes negotiate these environments is of intense
interest, not the least because protective immunity in schistosome
infections, when it occurs, appears to be directed against the early
intra-host stages, with the principal target being the lung stage
schistosomulum [2].
There is much to be learnt about the first few weeks of cercarial
establishment in the human host, but a detailed picture of the
molecular and cellular events during this time has been difficult to
obtain. The limitations arise partly because of the difficulties in
accessing material from experimental or natural infection, and
past technological limitations. Despite major advances in our
understanding of parasite transformation (reviewed recently in
[3]), and of the host–parasite interplay in early establishment [4],
there remain many questions, the answers to which will
undoubtedly guide discovery of novel targets for drugs and
vaccines. Some of the questions that are still unanswered are:
N What is it that makes young schistosomes susceptible to some
drugs (like artemether), while later developmental stages
appear refractory [5]? In contrast, why is praziquantel
ineffective against young schistosomula but effective against
adult worms [6]?
N How do host genetics and parasite activities interplay to allow
some people to respond effectively to parasite assault, while
other people remain susceptible?
N What is the purpose of the periods of sequestration in the skin
and the lung?
N What are the molecular and cellular events that are associated
with the surface transformation?
The ‘‘-omics’’ explosion in biology has more recently also
changed schistosomiasis research and enabled new ways of
addressing some of the above issues in schistosome–host
interactions. In recent issues of PLoS Neglected Tropical Diseases,
two papers that use such advanced analytical tools have been
published and both have advanced our understanding of the early
development of schistosome parasites in their human hosts.
Why Are Vaccinations with Radiation-Attenuated
Cercariae Successful?
The first paper, by Dillon and colleagues [7], describes an in
vitro model to explore the effects of radiation attenuation (RA) on
gene expression in mechanically transformed Schistosoma mansoni
cercariae. RA is a highly effective vaccine strategy, but the
mechanisms of its success are not understood. Using a microarray
designed to portray the transcriptome of lung-stage S. mansoni
schistosomula [8], the authors were able to analyse global
expression patterns of normal versus RA parasites at distinct time
points for periods of up to 10 days, by which time the
schistosomula would have migrated to the lungs. The authors
demonstrated that although there are distinct differences between
RA schistosomula and controls at various time points, the
overriding effect of RA is that of non-specific disruption of gene
expression, rather than enrichment of specific gene products. The
effect of RA, then, is simply that of retarding migration and
development of schistosomula, allowing time for the immune
system to recognise key parasite molecules and to mount a
protective response.
Cercarial Interactions in the Skin
In a second paper, published in this issue, Hansell and
colleagues [9] described proteomic analysis of S. mansoni cercarial
secretions in human skin after cercarial penetration and
transformation to schistosomula in vivo, as well as the host
peptides that are present around the invading cercaria. These
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authors used a recently amputated limb as a model for invasion of
human skin, which alone should ensure this article’s prominence
in the halls of ‘‘parasitological fame’’. Although the authors readily
admit that postmortem changes modify aspects of the skin
structure, the model does serve as a picture of early molecular
interactions of the transformed cercaria and its dermal environ-
ment. Newly penetrated larvae release a gamut of proteins from
the acetabular glands, including cercarial elastases, serpins,
paramyosin, and glutathione-S-transferases. Some of these mole-
cules have been already recognised as the ‘‘old guards’’ of
immunodominant vaccine candidates [10]. However, the present
findings may help to further our understanding of the involvement
of these molecules in host immune responsiveness. Other
molecules released over the timeframe of analysis include
tegument-associated antigens (Sm20.8) and other modulators of
immune response, including a protein that belongs to the venom
allergen-like protein family described for parasitic worms including
the schistosomes [11]. Hansell et al. also performed proteomic
analyses of the host dermal environment around the invading
cercaria.
The human skin environment potentially includes skin factors
associated with host responsiveness to the invasion of cercariae.
The authors concurrently analysed secreted molecules of the skin
to determine whether host proteins were either degraded by
cercarial secretions or accumulated because of invasion. Compar-
ison of skin exposed to cercariae, unexposed skin, and tissues
punctured by needles to mimic the intra-dermal tunnels created by
invading cercariae revealed that the physical barriers of epidermic,
basement membrane, and dermis are augmented with host
defence factors, such as complement components, immunoglob-
ulins, and protease inhibitors. Data consistent with the complexing
of the host protease inhibitors a-1-anti-trypsin and a-1-anti-
chymotrypsin with cercarial elastase were inferred from the
analyses. The presence of unmodified cercarial elastase perhaps
indicates that this innate defence strategy is overwhelmed by
invading cercariae. Complement components (C1 and C3) were
less abundant in skin tissues exposed to cercariae. This may
indicate that either the C3 pathway was activated in the skin in
response to invading cercariae, or was degraded by cercarial
proteases as a mechanism of immune evasion.
Uniting the ‘‘omes’’ of Schistosomes
(Schistosomics?)
Both contributions are inventive and demonstrate the power of
combining rational experimental design with the more recently
developed and available functional genomic tools to address
questions related to crucial stages in establishment of schistosome
infections. We now look forward to equally inventive strategies to
explore other aspects of schistosome biology and development,
given the complex transformation and ‘‘sojourn’’ of schistosomula
in their mammalian hosts. The combination of these platforms,
together with means for gene silencing or modification through
RNAi and stable transfections [12], should provide substantial new
information on parasite assault and host immunity. Microdissec-
tion methods will also enable analysis of the interplay within
specific tissue microenvironments [13], particularly when coupled
with transfected schistosomes expressing a fluorescent reporter
[14]. As these new areas develop, fundamental knowledge of the
secretome and surface structure of cercaria, the cell biology of
surface modification of transforming schistosomula, and the
repertoire of interactions among secreted parasite and tissue-
specific molecules of the host, would be more easily achieved.
References
1. Pearson JC (1956) Studies on the life cycles and morphology of the larval stages
of Alaria arisaemoides Augustine and Uribe, 1927 and Alaria canis LaRue and Fallis,
1936 (Trematoda: Diplostomidae). Can J Zool 34: 295–387.
2. Coulson PS (1997) The radiation-attenuated vaccine against schistosomes in
animal models: paradigm for a human vaccine? Adv Parasitol 39: 271–336.
3. Skelly PJ, Alan Wilson R (2006) Making sense of the schistosome surface. Adv
Parasitol 63: 185–284.
4. Jenkins SJ, Hewitson JP, Jenkins GR, Mountford AP (2005) Modulation of the
host’s immune response by schistosome larvae. Parasite Immunol 27: 385–393.
5. Xiao S, Catto B (1989) In vitro and in vivo studies of the effect of artemether on
Schistosoma mansoni. Antimicrob Agents Chemother 33: 1557–1562.
6. Sabah AA, Fletcher C, Webbe GMJD (1986) Schistosoma mansoni: chemotherapy
of infections of different ages. Exp Parasitol 61: 294–303.
7. Dillon GP, Feltwell T, Skelton J, Coulson PS, Wilson RA, et al. (2008) Altered
patterns of gene expression underlying the enhanced immunogenicity of
radiation-attenuated schistosomes. PLoS Negl Trop Dis 2: e240.
doi:210.1371/journal.pntd.0000240.
8. Dillon GP, Feltwell T, Skelton JP, Ashton PD, Coulson PS, et al. (2006)
Microarray analysis identifies genes preferentially expressed in the lung
schistosomulum of Schistosoma mansoni. Int J Parasitol 36: 1–8.
9. Hansell E, Braschi S, Medzihradszky KF, Sajid M, Debnath M, et al. (2008)
Proteomic analysis of skin invasion by blood fluke larvae. PLoS Negl Trop Dis 2:
e262. doi:210.1371/journal.pntd.0000262.
10. McManus DP, Loukas A (2008) Current status of vaccines for schistosomiasis.
Clin Microbiol Rev 21: 225–242.
11. Chalmers IW, McArdle AJ, Coulson RM, Wagner MA, Schmid R, et al. (2008)
Developmentally regulated expression, alternative splicing and distinct sub-
groupings in members of the Schistosoma mansoni venom allergen-like (SmVAL)
gene family. BMC Genomics 23: 89.
12. Ndegwa D, Krautz-Peterson G, Skelly PJ (2007) Protocols for gene silencing in
schistosomes. Exp Parasitol 117: 284–291.
13. Jones MK, Randall LM, McManus DP, Engwerda CR (2004) Laser
microdissection microscopy in parasitology: microscopes meet thermocyclers.
Trends Parasitol 20: 502–506.
14. Mann VH, Morales ME, Kines KJ, Brindley PJ (2008) Transgenesis of
schistosomes: approaches employing mobile genetic elements. Parasitology 135:
141–153.
www.plosntds.org 2 July 2008 | Volume 2 | Issue 7 | e257
